top of page

We provide 

life saving

medications

We are a contributor to a NHS National framework agreement for the supply of Normal Human Immunoglobulins

Oxbridge is 'bridging'
Science and Business, R&D and Market, and West and East

 

Oxbridge is proud to supply a selective range of prescription medicines that provide health benefit to patients suffering from various life threatening diseases. We are committed to improve the range of products available to partners involved in healthcare community through broadening their choice of products at affordable prices. ..read more

 

Product &
Therapy /

 

Oxbridge Pharma is internationally active in providing human plasma products, such as Human Immunoglobulin Intravenous, Human Serum Albumin and Prothrombin Complex. We are a reliable supplier of these state-of-the-art plasma-derived products for patients in Europe, the Middle East and Latin America. Our top priority is the health of patients - safety always comes first. ..read more

Quality &
Safety /

 

We are dedicated to supplying high-quality and safe biopharmaceuticals to save lives and improve the quality of life for patients who suffer from rare and serious diseases. The technologies employed in the manufacturing process of the products reflect our corporate dedication to quality and safety. ..read more

News /

 

 

 

 

 

In regard to the Framework Agreement appointing Oxbridge Pharma as a supplier of Normal Human Immunoglobulins, it is our pleasure to announce that Oxbridge Pharma Ltd has accepted an extension of the agreement for a 12 month period that was proposed by NHS, and will supply Aragam® through the period until the 31st May 2016.

Oxbridge is proud to continuously provide Aragam® to those people who are in need of this life saving medication in our home country.

 ..read more

Commendation letter from David Gigg, Office of the Crown Representative for SMEs

Oxbridge is introduced as one of the most successful Small and Medium Sized Enterprises (SMEs) on the UK Cabinet Office’s report ..read more

bottom of page